Application of natural and semi-synthetic polymers for the delivery of sensitive drugs

References

• des Rieux A, Fievez V, Garinot M, Schneider YJ and Preat V: ‘Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach’, J. Control. Release, 2006, 116, (1), 1–27.
   PubMed Web of Science ®Google Scholar
• Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX and Kissel T: ‘Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?’ Eur. J. Pharm. Biopharm., 2000, 50, (1), 147–160.
   PubMed Web of Science ®Google Scholar
• Woodley JF: ‘Enzymatic barriers for Gi peptide and protein delivery’, Crit. Rev. Ther. Drug, 1994, 11, (2–3), 61–95.
   PubMed Web of Science ®Google Scholar
• Cregg JM, Cereghino JL, Shi JY and Higgins DR: ‘Recombinant protein expression in Pichia pastoris’, Mol. Biotechnol., 2000, 16, (1), 23–52.
   PubMed Web of Science ®Google Scholar
• Huang CJ, Lin H and Yang XM: ‘Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements’, J. Ind. Microbiol. Biotechnol., 2012, 39, (3), 383–399.
   PubMed Web of Science ®Google Scholar
• Shukla AA, Hubbard B, Tressel T, Guhan S and Low D: ‘Downstream processing of monoclonal antibodies – application of platform approaches’, J. Chromatogr. B, 2007, 848, (1), 28–39.
   PubMed Web of Science ®Google Scholar
• Manning MC, Chou DK, Murphy BM, Payne RW and Katayama DS: ‘Stability of protein pharmaceuticals: an update’, Pharm. Res., 2010, 27, (4), 544–575.
   PubMed Web of Science ®Google Scholar
• Barnes LM, Bentley CM and Dickson AJ: ‘Stability of protein production from recombinant mammalian cells’, Biotechnol. Bioeng., 2003, 81, (6), 631–639.
   PubMed Web of Science ®Google Scholar
• Federici M, Lubiniecki A, Manikwar P and Volkin DB: ‘Analytical lessons learned from selected therapeutic protein drug comparability studies’, Biologicals, 2013, 41, (3), 131–147.
   PubMed Web of Science ®Google Scholar
• Cromwell MEM, Hilario E and Jacobson F: ‘Protein aggregation and bioprocessing’, AAPS J., 2006, 8, (3), E572–E579.
   PubMed Web of Science ®Google Scholar
• Kwon YM, Baudys M, Knutson K and Kim SW: ‘In situ study of insulin aggregation induced by water-organic solvent interface’, Pharm. Res., 2001, 18, (12), 1754–1759.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Chua KM and Wang CH: ‘Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres’, J. Colloid Interface Sci., 2004, 271, (1), 92–101.
   PubMed Web of Science ®Google Scholar
• De Rosa G, Iommelli R, La Rotonda MI, Miro A and Quaglia F: ‘Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres’, J. Control. Release, 2000, 69, (2), 283–295.
   PubMed Web of Science ®Google Scholar
• Jiang G, Woo BH, Kang FR, Singh J and DeLuca PP: ‘Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly (d,l-lactide-co-glycolide) microspheres’, J. Control. Release, 2002, 79, (1–3), 137–145.
   PubMed Web of Science ®Google Scholar
• Paillard-Giteau A, Tran VT, Thomas O, Garric X, Coudane J, Marchal S, Chourpa I, Benoit JP, Montero-Menei CN and Venier-Julienne MC: ‘Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique’, Eur. J. Pharm. Biopharm., 2010, 75, (2), 128–136.
   PubMed Web of Science ®Google Scholar
• Kim HK and Park TG: ‘Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism’, Biotechnol. Bioeng., 1999, 65, (6), 659–667.
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang YX, Kang AJ, Wang W, Ho SV, Gao JF, Ma GH and Su ZG: ‘A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles’, Mol. Pharm., 2012, 9, (7), 2039–2048.
   PubMed Web of Science ®Google Scholar
• He JT, Feng MY, Zhou XL, Ma SF, Jiang Y, Wang Y and Zhang HX: ‘Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer’, Int. J. Pharm., 2011, 416, (1), 69–76.
   PubMed Web of Science ®Google Scholar
• Schmidt PG, Campbell KM, Hinds KD and Cook GP: ‘PEGylated bioactive molecules in biodegradable polymer microparticles’, Expert Opin. Biol. Ther., 2007, 7, (9), 1427–1436.
   PubMed Web of Science ®Google Scholar
• Houchin ML and Topp EM: ‘Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms’, J. Pharm. Sci., 2008, 97, (7), 2395–2404.
   PubMed Web of Science ®Google Scholar
• Fu K, Pack DW, Klibanov AM and Langer R: ‘Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres’, Pharm. Res., 2000, 17, (1), 100–106.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Elkharraz K, Siepmann F and Klose D: ‘How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment’, Biomacromolecules, 2005, 6, (4), 2312–2319.
   PubMed Web of Science ®Google Scholar
• Anderson JM and Shive MS: ‘Biodegradation and biocompatibility of PLA and PLGA microspheres’, Adv. Drug Deliv. Rev., 1997, 28, (1), 5–24.
   PubMed Web of Science ®Google Scholar
• Du JJ, Jin J, Yan M and Lu YF: ‘Synthetic nanocarriers for intracellular protein delivery’, Curr. Drug Metab., 2012, 13, (1), 82–92.
   PubMed Web of Science ®Google Scholar
• Wagner E: ‘Polymers for siRNA Delivery: inspired by viruses to be targeted, dynamic, and precise’, Accounts Chem. Res., 2012, 45, (7), 1005–1013.
   PubMed Web of Science ®Google Scholar
• Nguyen J and Szoka FC: ‘Nucleic acid delivery: the missing pieces of the puzzle?’ Accounts Chem. Res., 2012, 45, (7), 1153–1162.
   PubMed Web of Science ®Google Scholar
• Behr JP: ‘Synthetic gene transfer vectors II: back to the future’, Accounts Chem. Res., 2012, 45, (7), 980–984.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Gunn J and Zhang MQ: ‘Chitosan-based hydrogels for controlled, localized drug delivery’, Adv. Drug Deliv. Rev., 2010, 62, (1), 83–99.
   PubMed Web of Science ®Google Scholar
• Mourya VK and Inamdar NN: ‘Chitosan-modifications and applications: opportunities galore’, React. Funct. Polym., 2008, 68, (6), 1013–1051.
   Web of Science ®Google Scholar
• Kumirska J, Weinhold MX, Czerwicka M, Kascynski Z, Bychowska A, Brzozowski K, Thöming J and Stepnowski P: ‘Influence of the chemical structure and physicochemical properties of chitin- and chitosan-based materials on their biomedical activity’, in ‘Biomedical engineering, trends in materials science’, (ed. A. N. Laskovski), 2011, Rijeka, Croatia, InTech.
   Google Scholar
• Nwe N, Chandrkrachang S, Stevens WF, Maw T, Tan TK, Khor E and Wong SM: ‘Production of fungal chitosan by solid state and submerged fermentation’, Carbohydr. Polym., 2002, 49, (2), 235–237.
   Web of Science ®Google Scholar
• Pochanavanich P and Suntornsuk W: ‘Fungal chitosan production and its characterization’, Lett. Appl. Microbiol., 2002, 35, (1), 17–21.
   PubMed Web of Science ®Google Scholar
• Wang QZ, Chen XG, Liu N, Wang SX, Liu CS, Meng XH and Liu CG: ‘Protonation constants of chitosan with different molecular weight and degree of deacetylation’, Carbohydr. Polym., 2006, 65, (2), 194–201.
   Web of Science ®Google Scholar
• Khalid MN, Agnely F, Yagoubi N, Grossiord JL and Couarraze G: ‘Water state characterization, swelling behavior, thermal and mechanical properties of chitosan based networks’, Eur. J. Pharm. Sci., 2002, 15, (5), 425–432.
   PubMed Web of Science ®Google Scholar
• Caner C, Vergano PJ and Wiles JL: ‘Chitosan film mechanical and permeation properties as affected by acid, plasticizer, and storage’, J. Food Sci., 1998, 63, (6), 1049–1053.
   Web of Science ®Google Scholar
• Nwe N, Furuike T and Tamura H: ‘The mechanical and biological properties of chitosan scaffolds for tissue regeneration templates are significantly enhanced by chitosan from Gongronella butleri’, Materials, 2009, 2, (2), 374–398.
   Web of Science ®Google Scholar
• Kean T and Thanou M: ‘Biodegradation, biodistribution and toxicity of chitosan’, Adv. Drug Deliv. Rev., 2010, 62, (1), 3–11.
   PubMed Web of Science ®Google Scholar
• Dash M, Chiellini F, Ottenbrite RM and Chiellini E: ‘Chitosan-A versatile semi-synthetic polymer in biomedical applications’, Prog. Polym. Sci., 2011, 36, (8), 981–1014.
   Web of Science ®Google Scholar
• Whang HS, Kirsch W, Zhu YH, Yang CZ and Hudson SM: ‘Hemostatic agents derived from chitin and chitosan’, J. Macromol. Sci., 2005, C45, (4), 309–323.
   Web of Science ®Google Scholar
• Illum L: ‘Chitosan and its use as a pharmaceutical excipient’, Pharm. Res., 1998, 15, (9), 1326–1331.
   PubMed Web of Science ®Google Scholar
• Schipper NGM, Varum KM and Artursson P: ‘Chitosans as absorption enhancers for poorly absorbable drugs.1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells’, Pharm. Res., 1996, 13, (11), 1686–1692.
   PubMed Web of Science ®Google Scholar
• Richardson SCW, Kolbe HJV and Duncan R: ‘Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA’, Int. J. Pharm., 1999, 178, (2), 231–243.
   PubMed Web of Science ®Google Scholar
• Hirano S, Iwata M, Yamanaka K, Tanaka H, Toda T and Inui H: ‘Enhancement of serum lysozyme activity by injecting a mixture of chitosan oligosaccharides intraveneously in rabbits’, Agric. Biol. Chem., 1991, 55, (10), 2623–2625.
   Google Scholar
• Rao SB and Sharma CP: ‘Use of chitosan as a biomaterial: studies on its safety and hemostatic potential’, J. Biomed. Mater. Res., 1997, 34, (1), 21–28.
   PubMed Web of Science ®Google Scholar
• Gades MD and Stern JS: ‘Chitosan supplementation and fecal fat excretion in men’, Obes. Res., 2003, 11, (5), 683–688.
   PubMedGoogle Scholar
• Arai K, Kinumaki T and Fujita T: ‘Toxity of chitosan’, Bull. Tokai Reg. Fish. Res. Lab., 1968, 56, 89–94.
   Google Scholar
• Funkhouser JD and Aronson NN: ‘Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family’, BMC Evol. Biol., 2007, 7, 96.
   PubMed Web of Science ®Google Scholar
• Jayakumar R, Chennazhi KP, Muzzarelli RAA, Tamura H, Nair SV and Selvamurugan N: ‘Chitosan conjugated DNA nanoparticles in gene therapy’, Carbohydr. Polym., 2010, 79, (1), 1–8.
   Web of Science ®Google Scholar
• Holzerny P, Ajdini B, Heusermann W, Bruno K, Schuleit M, Meinel L and Keller M: ‘Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity’, J. Control. Release, 2012, 157, (2), 297–304.
   PubMed Web of Science ®Google Scholar
• Mao SR, Sun W and Kissel T: ‘Chitosan-based formulations for delivery of DNA and siRNA’, Adv. Drug Deliv. Rev., 2010, 62, (1), 12–27.
   PubMed Web of Science ®Google Scholar
• Lai WF and Lin MCM: ‘Nucleic acid delivery with chitosan and its derivatives’, J. Control. Release, 2009, 134, (3), 158–168.
   PubMed Web of Science ®Google Scholar
• Sieval AB, Thanou M, Kotze AF, Verhoef JE, Brussee J and Junginger HE: ‘Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride’, Carbohydr. Polym., 1998, 36, (2–3), 157–165.
   Web of Science ®Google Scholar
• Kean T, Roth S and Thanou M: ‘Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency’, J. Control. Release, 2005, 103, (3), 643–653.
   PubMed Web of Science ®Google Scholar
• Kotze AF, Luessen HL, deLeeuw BJ, deBoer BG, Verhoef JC and Junginger HE: ‘N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2)’, Pharm. Res., 1997, 14, (9), 1197–1202.
   PubMed Web of Science ®Google Scholar
• Mao S, Germershaus O, Fischer D, Linn T, Schnepf R and Kissel T: ‘Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells’, Pharm. Res., 2005, 22, (12), 2058–2068.
   PubMed Web of Science ®Google Scholar
• Germershaus O, Mao SR, Sitterberg J, Bakowsky U and Kissel T: ‘Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro’, J. Control. Release, 2008, 125, (2), 145–154.
   PubMed Web of Science ®Google Scholar
• Mao SR, Shuai XT, Unger F, Wittmar M, Xie XL and Kissel T: ‘Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers’, Biomaterials, 2005, 26, (32), 6343–6356.
   PubMed Web of Science ®Google Scholar
• Behrens I, Pena AIV, Alonso MJ and Kissel T: ‘Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport’, Pharm. Res., 2002, 19, (8), 1185–1193.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS and Illum L: ‘In vitro evaluation of the mucoadhesive properties of chitosan microspheres’, Int. J. Pharm., 1998, 166, (1), 75–88.
   Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH and Junginger HE: ‘Invitro evaluation of mucoadhesive properties of chitosan and some other natural polymers’, Int. J. Pharm., 1992, 78, (1), 43–48.
   Web of Science ®Google Scholar
• Illum L, Farraj NF and Davis SS: ‘Chitosan as a novel nasal delivery system for peptide drugs’, Pharm. Res., 1994, 11, (8), 1186–1189.
   PubMed Web of Science ®Google Scholar
• Artursson P, Lindmark T, Davis SS and Illum L: ‘Effect of chitosan on the permeability of monolayers of intestinal epithelial-cells (Caco-2)’, Pharm. Res., 1994, 11, (9), 1358–1361.
   PubMed Web of Science ®Google Scholar
• Smith J, Wood E and Dornish M: ‘Effect of chitosan on epithelial cell tight junctions’, Pharm. Res., 2004, 21, (1), 43–49.
   PubMed Web of Science ®Google Scholar
• Kotze AF, Luessen HL, de Leeuw BJ, de Boer BG, Verhoef JC and Junginger HE: ‘Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)’, J. Control. Release, 1998, 51, (1), 35–46.
   PubMed Web of Science ®Google Scholar
• Schipper NGM, Varum KM, Stenberg P, Ocklind G, Lennernas H and Artursson P: ‘Chitosans as absorption enhancers of poorly absorbable drugs 3: influence of mucus on absorption enhancement’, Eur. J. Pharm. Sci., 1999, 8, (4), 335–343.
   PubMed Web of Science ®Google Scholar
• Fraser JRE, Laurent TC and Laurent UBG: ‘Hyaluronan: its nature, distribution, functions and turnover’, J. Intern. Med., 1997, 242, (1), 27–33.
   PubMed Web of Science ®Google Scholar
• Lago G, Oruna L, Cremata JA, Perez C, Coto G, Lauzan E and Kennedy JF: ‘Isolation, purification and characterization of hyaluronan from human umbilical cord residues’, Carbohydr. Polym., 2005, 62, (4), 321–326.
   Web of Science ®Google Scholar
• Vazquez JA, Montemayor MI, Fraguas J and Murado MA: ‘High production of hyaluronic and lactic acids by Streptococcus zooepidemicus in fed-batch culture using commercial and marine peptones from fishing by-products’, Biochem. Eng. J., 2009, 44, (2–3), 125–130.
   Web of Science ®Google Scholar
• Boeriu CG, Springer J, Kooy FK, van den Broek LAM and Eggink G: ‘Production methods for hyaluronan’, Int. J. Carbohydr. Chem., 2013, 2013, 14.
   Google Scholar
• Oh EJ, Park K, Kim KS, Kim J, Yang JA, Kong JH, Lee MY, Hoffman AS and Hahn SK: ‘Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives’, J. Control. Release, 2010, 141, (1), 2–12.
   PubMed Web of Science ®Google Scholar
• Larsen NE and Balazs EA: ‘Drug delivery systems using hyaluronan and its derivatives’, Adv. Drug Deliv. Rev., 1991, 7, (2), 279–293.
   Web of Science ®Google Scholar
• Stern R: ‘Hyaluronan catabolism: a new metabolic pathway’, Eur. J. Cell Biol., 2004, 83, (7), 317–325.
   PubMed Web of Science ®Google Scholar
• Jeon O, Song SJ, Lee KJ, Park MH, Lee SH, Hahn SK, Kim S and Kim BS: ‘Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities’, Carbohydr. Polym., 2007, 70, (3), 251–257.
   Web of Science ®Google Scholar
• Fujii T, Sun YL, An KN and Luo ZP: ‘Mechanical properties of single hyaluronan molecules’, J. Biomech., 2002, 35, (4), 527–531.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Sasaki M, Minamisawa Y, Kurahashi Y, Kano H and Ishikawa S: ‘Evaluation of in vivo biocompatibility and biodegradation of photocrosslinked hyaluronate hydrogels (HADgels)’, J. Biomed. Mater. Res. A, 2004, 70A, (4), 550–559.
   Web of Science ®Google Scholar
• Leach JB and Schmidt CE: ‘Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds’, Biomaterials, 2005, 26, (2), 125–135.
   PubMed Web of Science ®Google Scholar
• Seidlits SK, Khaing ZZ, Petersen RR, Nickels JD, Vanscoy JE, Shear JB and Schmidt CE: ‘The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation’, Biomaterials, 2010, 31, (14), 3930–3940.
   PubMed Web of Science ®Google Scholar
• Jansen K, van der Werff JFA, van Wachem PB, Nicolai JPA, de Leij LFMH and van Luyn MJA: ‘A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat’, Biomaterials, 2004, 25, (3), 483–489.
   PubMed Web of Science ®Google Scholar
• Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, Moras M and Abatangelo G: ‘Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats’, Biomaterials, 1993, 14, (15), 1154–1160.
   PubMed Web of Science ®Google Scholar
• Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G and Williams DF: ‘Semisynthetic resorbable materials from hyaluronan esterification’, Biomaterials, 1998, 19, (23), 2101–2127.
   PubMed Web of Science ®Google Scholar
• Liu YC, Shu XZ and Prestwich GD: ‘Biocompatibility and stability of disulfide-crosslinked hyaluronan films’, Biomaterials, 2005, 26, (23), 4737–4746.
   PubMed Web of Science ®Google Scholar
• Ottaviani RA, Wooley P, Song Z and Markel DC: ‘Inflammatory and immunological responses to hyaluronan preparations – study of a murine biocompatibility model’, J. Bone Joint Surg. Am., 2007, 89A, (1), 148–157.
   Web of Science ®Google Scholar
• Balazs EA: ‘Hyaluronan as an ophthalmic viscoelastic device’, Curr. Pharm. Biotechnol., 2008, 9, (4), 236–238.
   PubMed Web of Science ®Google Scholar
• Goa KL and Benfield P: ‘Hyaluronic-acid – a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound-healing’, Drugs, 1994, 47, (3), 536–566.
   PubMed Web of Science ®Google Scholar
• Rinaudo M: ‘Main properties and current applications of some polysaccharides as biomaterials’, Polym. Int., 2008, 57, (3), 397–430.
   Web of Science ®Google Scholar
• Garcia-Fuentes M, Meinel AJ, Hilbe M, Meinel L and Merkle HP: ‘Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering’, Biomaterials, 2009, 30, (28), 5068–5076.
   PubMed Web of Science ®Google Scholar
• Garcia-Fuentes M, Giger E, Meinel L and Merkle HP: ‘The effect of hyaluronic acid on silk fibroin conformation’, Biomaterials, 2008, 29, (6), 633–642.
   PubMed Web of Science ®Google Scholar
• Hoffman AS: ‘Hydrogels for biomedical applications’, Adv. Drug Deliv. Rev., 2002, 54, (1), 3–12.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Hahn SK, Kim MJ, Kim DH and Lee YP: ‘Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles’, J. Control. Release, 2005, 104, (2), 323–335.
   PubMed Web of Science ®Google Scholar
• Surendrakumar K, Martyn GP, Hodgers ECM, Jansen M and Blair JA: ‘Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs’, J. Control. Release, 2003, 91, (3), 385–394.
   PubMed Web of Science ®Google Scholar
• Yang JA, Kim H, Park K and Hahn SK: ‘Molecular design of hyaluronic acid hydrogel networks for long-term controlled delivery of human growth hormone’, Soft Matter, 2011, 7, (3), 868–870.
   Web of Science ®Google Scholar
• Xu KM, Lee F, Gao SJ, Chung JE, Yano H and Kurisawa M: ‘Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-alpha 2a for liver cancer therapy’, J. Control. Release, 2013, 166, (3), 203–210.
   PubMed Web of Science ®Google Scholar
• Lee F, Chung JE and Kurisawa M: ‘An injectable enzymatically crosslinked hyaluronic acid-tyramine hydrogel system with independent tuning of mechanical strength and gelation rate’, Soft Matter, 2008, 4, (4), 880–887.
   PubMed Web of Science ®Google Scholar
• Lee F, Chung JE and Kurisawa M: ‘An injectable hyaluronic acid-tyramine hydrogel system for protein delivery’, J. Control. Release, 2009, 134, (3), 186–193.
   PubMed Web of Science ®Google Scholar
• Byeon HJ, Choi SH, Choi JS, Kim I, Shin BS, Lee ES, Park ES, Lee KC and Youn YS: ‘Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer’, Acta Biomater., 2014, 10, (1), 142–150.
   PubMed Web of Science ®Google Scholar
• Choh SY, Cross D and Wang C: ‘Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation’, Biomacromolecules, 2011, 12, (4), 1126–1136.
   PubMed Web of Science ®Google Scholar
• Zhang R, Huang ZB, Xue MY, Yang J and Tan TW: ‘Detailed characterization of an injectable hyaluronic acid-polyaspartylhydrazide hydrogel for protein delivery’, Carbohydr. Polym., 2011, 85, (4), 717–725.
   Web of Science ®Google Scholar
• Kim J, Kim IS, Cho TH, Kim HC, Yoon SJ, Choi J, Park Y, Sun K and Hwang SJ: ‘In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering’, J. Biomed. Mater. Res. A, 2010, 95A, (3), 673–681.
   Web of Science ®Google Scholar
• Kim J, Park Y, Tae G, Lee KB, Hwang SJ, Kim IS, Noh I and Sun K: ‘Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels’, J. Mater. Sci. Mater. Med., 2008, 19, (11), 3311–3318.
   PubMed Web of Science ®Google Scholar
• Yang JA, Kim ES, Kwon JH, Kim H, Shin JH, Yun SH, Choi KY and Hahn SK: ‘Transdermal delivery of hyaluronic acid – human growth hormone conjugate’, Biomaterials, 2012, 33, (25), 5947–5954.
   PubMed Web of Science ®Google Scholar
• Mero A, Pasqualin M, Campisi M, Renier D and Pasut G: ‘Conjugation of hyaluronan to proteins’, Carbohydr. Polym., 2013, 92, (2), 2163–2170.
   PubMed Web of Science ®Google Scholar
• Ferguson EL, Alshame AMJ and Thomas DW: ‘Evaluation of hyaluronic acid-protein conjugates for polymer masked-unmasked protein therapy’, Int. J. Pharm., 2010, 402, (1–2), 95–102.
   PubMed Web of Science ®Google Scholar
• Grasdalen H, Larsen B and Smidsrod O: ‘C-13-Nmr studies of monomeric composition and sequence in alginate’, Carbohyd. Res., 1981, 89, (2), 179–191.
   Web of Science ®Google Scholar
• Simpson NE, Stabler CL, Simpson CP, Sambanis A and Constantinidis L: ‘The role of the CaCl2-guluronic acid interaction on alginate encapsulated beta TC3 cells’, Biomaterials, 2004, 25, (13), 2603–2610.
   PubMed Web of Science ®Google Scholar
• DeVos P, DeHaan B, Wolters GHJ and VanSchilfgaarde R: ‘Factors influencing the adequacy of microencapsulation of rat pancreatic islets’, Transplantation, 1996, 62, (7), 888–893.
   PubMed Web of Science ®Google Scholar
• Cuadros TR, Skurtys O and Aguilera JM: ‘Mechanical properties of calcium alginate fibers produced with a microfluidic device’, Carbohydr. Polym., 2012, 89, (4), 1198–1206.
   PubMed Web of Science ®Google Scholar
• Davidovich-Pinhas M and Bianco-Peled H: ‘A quantitative analysis of alginate swelling’, Carbohydr. Polym., 2010, 79, (4), 1020–1027.
   Web of Science ®Google Scholar
• Schneider S, Feilen PJ, Kraus O, Haase T, Sagban TA, Lehr HA, Beyer J, Pommersheim R and Weber MM: ‘Biocompatibility of alginates for grafting: impact of alginate molecular weight’, Artif. Cells Blood Substit. Immobil. Biotechnol., 2003, 31, (4), 383–394.
   PubMedGoogle Scholar
• DeVos P, DeHaan B and VanSchilfgaarde R: ‘Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules’, Biomaterials, 1997, 18, (3), 273–278.
   PubMed Web of Science ®Google Scholar
• Tam SK, Dusseault J, Bilodeau S, Langlois G, Halle JP and Yahia L: ‘Factors influencing alginate gel biocompatibility’, J. Biomed. Mater. Res. A, 2011, 98A, (1), 40–52.
   Web of Science ®Google Scholar
• Otterlei M, Ostgaard K, Skjakbraek G, Smidsrod O, Soonshiong P and Espevik T: ‘Induction of cytokine production from human monocytes stimulated with alginate’, J. Immunother., 1991, 10, (4), 286–291.
   PubMed Web of Science ®Google Scholar
• Espevik T, Otterlei M, Skjakbraek G, Ryan L, Wright SD and Sundan A: ‘The involvement of Cd14 in stimulation of cytokine production by uronic-acid polymers’, Eur. J. Immunol., 1993, 23, (1), 255–261.
   PubMed Web of Science ®Google Scholar
• Alshamkhani A and Duncan R: ‘Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivo’, J. Bioact. Compat. Polym., 1995, 10, (1), 4–13.
   Web of Science ®Google Scholar
• Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW and Mooney DJ: ‘Degradation of partially oxidized alginate and its potential application for tissue engineering’, Biotechnol. Prog., 2001, 17, (5), 945–950.
   PubMed Web of Science ®Google Scholar
• Pescosolido L, Piro T, Vermonden T, Coviello T, Alhaique F, Hennink WE and Matricardi P: ‘Biodegradable IPNs based on oxidized alginate and dextran-HEMA for controlled release of proteins’, Carbohydr. Polym., 2011, 86, (1), 208–213.
   Web of Science ®Google Scholar
• Jeon O, Bouhadir KH, Mansour JM and Alsberg E: ‘Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties’, Biomaterials, 2009, 30, (14), 2724–2734.
   PubMed Web of Science ®Google Scholar
• Schweizer D, Schonhammer K, Jahn M and Gopferich A: ‘Protein-polyanion interactions for the controlled release of monoclonal antibodies’, Biomacromolecules, 2013, 14, (1), 75–83.
   PubMed Web of Science ®Google Scholar
• Mobus K, Siepmann J and Bodmeier R: ‘Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying’, Eur. J. Pharm. Biopharm., 2012, 81, (1), 121–130.
   PubMed Web of Science ®Google Scholar
• Jay SM and Saltzman WM: ‘Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking’, J. Control. Release, 2009, 134, (1), 26–34.
   PubMed Web of Science ®Google Scholar
• Bochek AM: ‘Effect of hydrogen bonding on cellulose solubility in aqueous and nonaqueous solvents’, Russ. J. Appl. Chem., 2003, 76, (11), 1711–1719.
   Web of Science ®Google Scholar
• Czaja WK, Young DJ, Kawecki M and Brown RM: ‘The future prospects of microbial cellulose in biomedical applications’, Biomacromolecules, 2007, 8, (1), 1–12.
   PubMed Web of Science ®Google Scholar
• Helenius G, Backdahl H, Bodin A, Nannmark U, Gatenholm P and Risberg B: ‘In vivo biocompatibility of bacterial cellulose’, J. Biomed. Mater. Res. A, 2006, 76A, (2), 431–438.
   Web of Science ®Google Scholar
• El-Saied H, Basta AH and Gobran RH: ‘Research progress in friendly environmental technology for the production of cellulose products (bacterial cellulose and its application)’, Polym.-Plast. Technol. Eng., 2004, 43, (3), 797–820.
   Web of Science ®Google Scholar
• Muller A, Ni ZX, Hessler N, Wesarg F, Muller FA, Kralisch D and Fischer D: ‘The biopolymer bacterial nanocellulose as drug delivery system: investigation of drug loading and release using the model protein albumin’, J. Pharm. Sci., 2013, 102, (2), 579–592.
   PubMed Web of Science ®Google Scholar
• Czaja W, Romanovicz D and Brown RM: ‘Structural investigations of microbial cellulose produced in stationary and agitated culture’, Cellulose, 2004, 11, (3–4), 403–411.
   Web of Science ®Google Scholar
• Tanpichai S, Quero F, Nogi M, Yano H, Young RJ, Lindstrom T, Sampson WW and Eichhorn SJ: ‘Effective young's modulus of bacterial and microfibrillated cellulose fibrils in fibrous networks’, Biomacromolecules, 2012, 13, (5), 1340–1349.
   PubMed Web of Science ®Google Scholar
• Guhados G, Wan WK and Hutter JL: ‘Measurement of the elastic modulus of single bacterial cellulose fibers using atomic force microscopy’, Langmuir, 2005, 21, (14), 6642–6646.
   PubMed Web of Science ®Google Scholar
• Lee KY, Buldum G, Mantalaris A and Bismarck A: ‘More than meets the eye in bacterial cellulose: biosynthesis, bioprocessing, and applications in advanced fiber composites’, Macromol. Biosci., 2014, 14, (1), 10–32.
   PubMed Web of Science ®Google Scholar
• Zahedi P, Rezaeian I, Ranaei-Siadat SO, Jafari SH and Supaphol P: ‘A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages’, Polym. Adv. Technol., 2010, 21, (2), 77–95.
   Web of Science ®Google Scholar
• Kuzmenko V, Samfors S, Hagg D and Gatenholm P: ‘Universal method for protein bioconjugation with nanocellulose scaffolds for increased cell adhesion’, Mater. Sci. Eng. C Mater. Biol. Appl., 2013, 33, (8), 4599–4607.
   PubMed Web of Science ®Google Scholar
• Petersen N and Gatenholm P: ‘Bacterial cellulose-based materials and medical devices: current state and perspectives’, Appl. Microbiol. Biotechnol., 2011, 91, (5), 1277–1286.
   PubMed Web of Science ®Google Scholar
• Martson M, Viljanto J, Hurme T, Laippala P and Saukko P: ‘Is cellulose sponge degradable or stable as implantation material? An in vivo subcutaneous study in the rat’, Biomaterials, 1999, 20, (21), 1989–1995.
   PubMed Web of Science ®Google Scholar
• Kino Y, Sawa M, Kasai S and Mito M: ‘Multiporous cellulose microcarrier for the development of a hybrid artificial liver using isolated hepatocytes’, J. Surg. Res., 1998, 79, (1), 71–76.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Takahashi S, Ito H, Inagaki H and Noishiki Y: ‘Tissue biocompatibility of cellulose and its derivatives’, J. Biomed. Mater. Res., 1989, 23, (1), 125–133.
   PubMed Web of Science ®Google Scholar
• Song YB, Sun YX, Zhang XZ, Zhou JP and Zhang LN: ‘Homogeneous quaternization of cellulose in NaOH/urea aqueous solutions as gene carriers’, Biomacromolecules, 2008, 9, (8), 2259–2264.
   PubMed Web of Science ®Google Scholar
• Song YB, Zhou JP, Li Q, Guo Y and Zhang LN: ‘Preparation and characterization of novel quaternized cellulose nanoparticles as protein carriers’, Macromol. Biosci., 2009, 9, (9), 857–863.
   PubMed Web of Science ®Google Scholar
• Tripathy J and Raichur AM: ‘Designing carboxymethyl cellulose based layer-by-layer capsules as a carrier for protein delivery’, Colloid Surface B, 2013, 101, 487–492.
   PubMed Web of Science ®Google Scholar
• Shi Q, Li Y, Sun J, Zhang H, Chen L, Chen B, Yang HL and Wang ZX: ‘The osteogenesis of bacterial cellulose scaffold loaded with bone morphogenetic protein-2’, Biomaterials, 2012, 33, (28), 6644–6649.
   PubMed Web of Science ®Google Scholar
• Weisel JW: ‘The mechanical properties of fibrin for basic scientists and clinicians’, Biophys. Chem., 2004, 112, (2–3), 267–276.
   PubMed Web of Science ®Google Scholar
• Fuss C, Palmaz JC and Sprague EA: ‘Fibrinogen: structure, function, and surface interactions’, J. Vasc. Interv. Radiol., 2001, 12, (6), 677–682.
   PubMed Web of Science ®Google Scholar
• Mosesson MW: ‘Fibrinogen and fibrin structure and functions’, J. Thromb. Haemost., 2005, 3, (8), 1894–1904.
   PubMed Web of Science ®Google Scholar
• Pankov R and Yamada KM: ‘Fibronectin at a glance’, J. Cell Sci., 2002, 115, (Pt 20), 3861–3863.
   PubMed Web of Science ®Google Scholar
• Dugan TA, Yang VW, McQuillan DJ and Hook M: ‘Decorin modulates fibrin assembly and structure’, J. Biol. Chem., 2006, 281, (50), 38208–38216.
   PubMed Web of Science ®Google Scholar
• Sahni A, Odrljin T and Francis CW: ‘Binding of basic fibroblast growth factor to fibrinogen and fibrin’, J. Biol. Chem., 1998, 273, (13), 7554–7559.
   PubMed Web of Science ®Google Scholar
• Sahni A and Francis CW: ‘Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation’, Blood, 2000, 96, (12), 3772–3778.
   PubMed Web of Science ®Google Scholar
• Liu W, Jawerth LM, Sparks EA, Falvo MR, Hantgan RR, Superfine R, Lord ST and Guthold M: ‘Fibrin fibers have extraordinary extensibility and elasticity’, Science, 2006, 313, (5787), 634.
   PubMed Web of Science ®Google Scholar
• Guthold M, Liu W, Sparks EA, Jawerth LM, Peng L, Falvo M, Superfine R, Hantgan RR and Lord ST: ‘A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers’, Cell Biochem. Biophys., 2007, 49, (3), 165–181.
   PubMed Web of Science ®Google Scholar
• Collet JP, Shuman H, Ledger RE, Lee S and Weisel JW: ‘The elasticity of an individual fibrin fiber in a clot’, Proc. Natl. Acad. Sci. U.S.A., 2005, 102, (26), 9133–9137.
   PubMed Web of Science ®Google Scholar
• Ferry JD and Morrison PR: ‘Preparation and properties of serum and plasma proteins: human fibrin in the form of an elastic film’, J. Am. Chem. Soc., 1947, 69, (2), 400–409.
   PubMed Web of Science ®Google Scholar
• Stenhagen E: ‘Electrophoresis of human blood plasma: electrophoretic properties of fibrinogen’, Biochem. J., 1938, 32, (4), 714–718.
   PubMedGoogle Scholar
• Ho HO, Hsiao CC, Sokoloski TD, Chen CY and Sheu MT: ‘Fibrin-based drug-delivery systems.3. The evaluation of the release of macromolecules from microbeads’, J. Control. Release, 1995, 34, (1), 65–70.
   Web of Science ®Google Scholar
• Raeber GP, Lutolf MP and Hubbell JA: ‘Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration’, Biophys. J., 2005, 89, (2), 1374–1388.
   PubMed Web of Science ®Google Scholar
• Urech L, Bittermann AG, Hubbell JA and Hall H: ‘Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro’, Biomaterials, 2005, 26, (12), 1369–1379.
   PubMed Web of Science ®Google Scholar
• Spicer PP and Mikos AG: ‘Fibrin glue as a drug delivery system’, J. Control. Release, 2010, 148, (1), 49–55.
   PubMed Web of Science ®Google Scholar
• Kulkarni M, Breen A, Greiser U, O'Brien T and Pandit A: ‘Fibrin-lipoplex system for controlled topical delivery of multiple genes’, Biomacromolecules, 2009, 10, (6), 1650–1654.
   PubMed Web of Science ®Google Scholar
• des Rieux A, Shikanov A and Shea LD: ‘Fibrin hydrogels for non-viral vector delivery in vitro’, J. Control. Release, 2009, 136, (2), 148–154.
   PubMed Web of Science ®Google Scholar
• Lei P, Padmashali RM and Andreadis ST: ‘Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels’, Biomaterials, 2009, 30, (22), 3790–3799.
   PubMed Web of Science ®Google Scholar
• Trentin D, Hubbell J and Hall H: ‘Non-viral gene delivery for local and controlled DNA release’, J. Control. Release, 2005, 102, (1), 263–275.
   PubMed Web of Science ®Google Scholar
• Trentin D, Hall H, Wechsler S and Hubbell JA: ‘Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis’, Proc. Natl. Acad. Sci. U.S.A., 2006, 103, (8), 2506–2511.
   PubMed Web of Science ®Google Scholar
• Thiersch M, Rimann M, Panagiotopoulou V, Ozturk E, Biedermann T, Textor M, Luhmann TC and Hall H: ‘The angiogenic response to PLL-g-PEG-mediated HIF-1alpha plasmid DNA delivery in healthy and diabetic rats’, Biomaterials, 2013, 34, (16), 4173–4182.
   PubMed Web of Science ®Google Scholar
• Saul JM, Linnes MP, Ratner BD, Giachelli CM and Pun SH: ‘Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression’, Biomaterials, 2007, 28, (31), 4705–4716.
   PubMed Web of Science ®Google Scholar
• Losi P, Briganti E, Errico C, Lisella A, Sanguinetti E, Chiellini F and Soldani G: ‘Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice’, Acta Biomater., 2013, 9, (8), 7814–7821.
   PubMed Web of Science ®Google Scholar
• Shikanov A, Zhang Z, Xu M, Smith RM, Rajan A, Woodruff TK and Shea LD: ‘Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice’, Tissue Eng. Part A, 2011, 17, (23–24), 3095–3104.
   PubMed Web of Science ®Google Scholar
• Bhang SH, Sun AY, Yang HS, Rhim T, Kim DI and Kim BS: ‘Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin’, Biotechnol. Lett., 2011, 33, (4), 845–851.
   PubMed Web of Science ®Google Scholar
• Layman H, Li X, Nagar E, Vial X, Pham SM and Andreopoulos FM: ‘Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres’, J. Biomater. Sci. Polym. Ed., 2012, 23, (1–4), 185–206.
   PubMed Web of Science ®Google Scholar
• Bhang SH, Lee TJ, La WG, Kim DI and Kim BS: ‘Delivery of fibroblast growth factor 2 enhances the viability of cord blood-derived mesenchymal stem cells transplanted to ischemic limbs’, J. Biosci. Bioeng., 2011, 111, (5), 584–589.
   PubMed Web of Science ®Google Scholar
• Schense JC, Bloch J, Aebischer P and Hubbell JA: ‘Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension’, Nat. Biotechnol., 2000, 18, (4), 415–419.
   PubMed Web of Science ®Google Scholar
• Schense JC and Hubbell JA: ‘Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa’, Bioconjug Chem., 1999, 10, (1), 75–81.
   PubMed Web of Science ®Google Scholar
• Lienemann PS, Lutolf MP and Ehrbar M: ‘Biomimetic hydrogels for controlled biomolecule delivery to augment bone regeneration’, Adv. Drug Deliv. Rev., 2012, 64, (12), 1078–1089.
   PubMed Web of Science ®Google Scholar
• Luhmann T, Hanseler P, Grant B and Hall H: ‘The induction of cell alignment by covalently immobilized gradients of the 6th Ig-like domain of cell adhesion molecule L1 in 3D-fibrin matrices’, Biomaterials, 2009, 30, (27), 4503–4512.
   PubMed Web of Science ®Google Scholar
• Hall H: ‘Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis’, Curr. Pharm. Des., 2007, 13, (35), 3597–3607.
   PubMed Web of Science ®Google Scholar
• Martino MM, Briquez PS, Ranga A, Lutolf MP and Hubbell JA: ‘Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix’, Proc. Natl. Acad. Sci. U.S.A., 2013, 110, (12), 4563–4568.
   PubMed Web of Science ®Google Scholar
• Kadler KE, Hill A and Canty-Laird EG: ‘Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators’, Curr. Opin. Cell Biol., 2008, 20, (5), 495–501.
   PubMed Web of Science ®Google Scholar
• Friess W: ‘Collagen – biomaterial for drug delivery’, Eur. J. Pharm. Biopharm., 1998, 45, (2), 113–136.
   PubMed Web of Science ®Google Scholar
• Kadler KE, Holmes DF, Trotter JA and Chapman JA: ‘Collagen fibril formation’, Biochem. J., 1996, 316, (Pt 1), 1–11.
   PubMed Web of Science ®Google Scholar
• Gelse K, Poschl E and Aigner T: ‘Collagens – structure, function, and biosynthesis’, Adv. Drug Deliv. Rev., 2003, 55, (12), 1531–1546.
   PubMed Web of Science ®Google Scholar
• Gansler H and Nemetschek T: ‘[The swelling of collagen fibrils]’, Z Naturforsch B, 1960, 15B, 414.
   PubMedGoogle Scholar
• Wood GC: ‘The formation of fibrils from collagen solutions. 2. A mechanism of collagen-fibril formation’, Biochem. J., 1960, 75, 598–605.
   PubMed Web of Science ®Google Scholar
• Gross J: ‘Studies on the formation of collagen.1. Properties and fractionation of neutral salt extracts of normal guinea pig connective tissue’, J. Exp. Med., 1958, 107, (2), 247–263.
   PubMed Web of Science ®Google Scholar
• Gross J and Kirk D: ‘Heat precipitation of collagen from neutral salt solutions – some rate-regulating factors’, J. Biol. Chem., 1958, 233, (2), 355–360.
   PubMed Web of Science ®Google Scholar
• Gelman RA, Williams BR and Piez KA: ‘Collagen fibril formation. Evidence for a multistep process’, J. Biol. Chem., 1979, 254, (1), 180–186.
   PubMed Web of Science ®Google Scholar
• Suarez G, Oronsky AL, Bordas J and Koch MH: ‘Synchrotron radiation x-ray scattering in the early stages of in vitro collagen fibril formation’, Proc. Natl. Acad. Sci. U.S.A., 1985, 82, (14), 4693–4696.
   PubMed Web of Science ®Google Scholar
• Mertz EL and Leikin S: ‘Interactions of inorganic phosphate and sulfate anions with collagen’, Biochemistry, 2004, 43, (47), 14901–14912.
   PubMed Web of Science ®Google Scholar
• de Wild M, Pomp W and Koenderink GH: ‘Thermal memory in self-assembled collagen fibril networks’, Biophys. J., 2013, 105, (1), 200–210.
   PubMed Web of Science ®Google Scholar
• Silver FH, Christiansen D, Snowhill PB, Chen Y and Landis WJ: ‘The role of mineral in the storage of elastic energy in turkey tendons’, Biomacromolecules, 2000, 1, (2), 180–185.
   PubMed Web of Science ®Google Scholar
• Uquillas JA and Akkus O: ‘Modeling the electromobility of type-I collagen molecules in the electrochemical fabrication of dense and aligned tissue constructs’, Ann. Biomed. Eng., 2012, 40, (8), 1641–1653.
   PubMed Web of Science ®Google Scholar
• Mello ML, Vidal BC and Valdrighi L: ‘Anisotropy and isoelectrical point determinations on collagen bundles of the rat periodontal fibers’, Histochemistry, 1974, 42, (2), 163–174.
   PubMedGoogle Scholar
• Ma L, Gao C, Mao Z, Zhou J and Shen J: ‘Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges’, Biomaterials, 2004, 25, (15), 2997–3004.
   PubMed Web of Science ®Google Scholar
• Parenteau-Bareil R, Gauvin R and Berthod F: ‘Collagen-based biomaterials for tissue engineering applications’, Materials, 2010, 3, (3), 1863–1887.
   Web of Science ®Google Scholar
• Lee CH, Singla A and Lee Y: ‘Biomedical applications of collagen’, Int. J. Pharm., 2001, 221, (1–2), 1–22.
   PubMed Web of Science ®Google Scholar
• Olsen D, Yang C, Bodo M, Chang R, Leigh S, Baez J, Carmichael D, Perala M, Hamalainen ER, Jarvinen M and Polarek J: ‘Recombinant collagen and gelatin for drug delivery’, Adv. Drug Deliv. Rev., 2003, 55, (12), 1547–1567.
   PubMed Web of Science ®Google Scholar
• Wallace DG and Rosenblatt J: ‘Collagen gel systems for sustained delivery and tissue engineering’, Adv. Drug Deliv. Rev., 2003, 55, (12), 1631–1649.
   PubMed Web of Science ®Google Scholar
• Scherer F, Schillinger U, Putz U, Stemberger A and Plank C: ‘Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo’, J. Gene Med., 2002, 4, (6), 634–643.
   PubMed Web of Science ®Google Scholar
• Tierney EG, Duffy GP, Hibbitts AJ, Cryan SA and O'Brien FJ: ‘The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds’, J. Control. Release, 2012, 158, (2), 304–311.
   PubMed Web of Science ®Google Scholar
• Reckhenrich AK, Hopfner U, Krotz F, Zhang Z, Koch C, Kremer M, Machens HG, Plank C and Egana JT: ‘Bioactivation of dermal scaffolds with a non-viral copolymer-protected gene vector’, Biomaterials, 2011, 32, (7), 1996–2003.
   PubMed Web of Science ®Google Scholar
• Capito RM and Spector M: ‘Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering’, Gene Ther., 2007, 14, (9), 721–732.
   PubMed Web of Science ®Google Scholar
• Lutz R, Park J, Felszeghy E, Wiltfang J, Nkenke E and Schlegel KA: ‘Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects’, Clin. Oral Implants Res., 2008, 19, (6), 590–599.
   PubMed Web of Science ®Google Scholar
• Premaraj S and Moursi AM: ‘Delivery of transforming growth factor-beta3 plasmid in a collagen gel inhibits cranial suture fusion in rats’, Cleft Palate Craniofac. J., 2013, 50, (3), e47–e60.
   PubMed Web of Science ®Google Scholar
• Krebs MD, Jeon O and Alsberg E: ‘Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels’, J. Am. Chem. Soc., 2009, 131, (26), 9204–9206.
   PubMed Web of Science ®Google Scholar
• Bhakta G, Lim ZX, Rai B, Lin T, Hui JH, Prestwich GD, van Wijnen AJ, Nurcombe V and Cool SM: ‘The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation’, Acta Biomater., 2013, 9, (11), 9098–9106.
   PubMed Web of Science ®Google Scholar
• Yang HS, La WG, Cho YM, Shin W, Yeo GD and Kim BS: ‘Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration’, Exp. Mol. Med., 2012, 44, (5), 350–355.
   PubMed Web of Science ®Google Scholar
• Nitta SK and Numata K: ‘Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering’, Int. J. Mol. Sci., 2013, 14, (1), 1629–1654.
   PubMed Web of Science ®Google Scholar
• Djagny VB, Wang Z and Xu S: ‘Gelatin: a valuable protein for food and pharmaceutical industries: review’, Crit. Rev. Food Sci. Nutr., 2001, 41, (6), 481–492.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration: ‘Guidance for industry – the sourcing and processing of gelatin to reduce the potential risk posed by bovine spongiform encephalopathy (BSE) in FDA-regulated products for human use’; 1997, Silver Spring, Food and Drug Administration.
   Google Scholar
• Won YW and Kim YH: ‘Preparation and cytotoxicity comparison of type A gelatin nanoparticles with recombinant human gelatin nanoparticles’, Macromol. Res., 2009, 17, (7), 464–468.
   Web of Science ®Google Scholar
• Vandelli MA, Rivasi F, Guerra P, Forni F and Arletti R: ‘Gelatin microspheres crosslinked with d,l-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies’, Int. J. Pharm., 2001, 215, (1–2), 175–184.
   PubMed Web of Science ®Google Scholar
• Speer DP, Chvapil M, Eskelson CD and Ulreich J: ‘Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials’, J. Biomed. Mater. Res., 1980, 14, (6), 753–764.
   PubMed Web of Science ®Google Scholar
• Brzoska M, Langer K, Coester C, Loitsch S, Wagner TOF and Mallinckrodt CV: ‘Incorporation of biodegradable nanoparticles into human airway epithelium cells – in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases’, Biochem. Biophys. Res. Commun., 2004, 318, (2), 562–570.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M, Yarwood SJ and Curtis ASG: ‘Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts’, J. Control. Release, 2004, 95, (2), 197–207.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Khan SA, Park JK and Lim KH: ‘Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation’, Bioprocess Biosyst. Eng., 2012, 35, (1–2), 297–307.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Li X, Lu CT, Xu YY, Lv HF, Dai DD, Zhang L, Sun CZ, Yang W, Li XK, Zhao YP, Fu HX, Cai L, Lin M, Chen LJ and Zhang M: ‘Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy’, Acta Diabetol., 2012, 49, (4), 315–325.
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, van Briesen H and Kreuter J: ‘Gelatin nanoparticles by two step desolvation – a new preparation method, surface modifications and cell uptake’, J. Microencapsul., 2000, 17, (2), 187–193.
   PubMed Web of Science ®Google Scholar
• Leo E, Arletti R, Forni F and Cameroni R: ‘General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles’, Farmaco, 1997, 52, (6–7), 385–388.
   PubMedGoogle Scholar
• Mimi H, Ho KM, Siu YS, Wu A and Li P: ‘Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells’, J. Control. Release, 2012, 158, (1), 123–130.
   PubMed Web of Science ®Google Scholar
• Gan ZH, Ju JH, Zhang T and Wu DC: ‘Preparation of rhodamine B fluorescent poly(methacrylic acid) coated gelatin nanoparticles’, J. Nanomater., 2011, 2011, 8.
   Web of Science ®Google Scholar
• Li WM, Liu DM and Chen SY: ‘Amphiphilically-modified gelatin nanoparticles: self-assembly behavior, controlled biodegradability, and rapid cellular uptake for intracellular drug delivery’, J. Mater. Chem., 2011, 21, (33), 12381–12388.
   Web of Science ®Google Scholar
• Won YW and Kim YH: ‘Recombinant human gelatin nanoparticles as a protein drug carrier’, J. Control. Release, 2008, 127, (2), 154–161.
   PubMed Web of Science ®Google Scholar
• Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J and Langer K: ‘Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes’, Biomaterials, 2005, 26, (15), 2723–2732.
   PubMed Web of Science ®Google Scholar
• Tseng CL, Wu SYH, Wang WH, Peng CL, Lin FH, Lin CC, Young TH and Shieh MJ: ‘Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer’, Biomaterials, 2008, 29, (20), 3014–3022.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Chono S, Kosai T, Seki T and Tabata Y: ‘Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs’, Drug Deliv., 2008, 15, (2), 113–117.
   PubMed Web of Science ®Google Scholar
• Lopez-Cebral R, Martin-Pastor M, Parraga JE, Zorzi GK, Seijo B and Sanchez A: ‘Chemically modified gelatin as biomaterial in the design of new nanomedicines’, Med. Chem., 2011, 7, (3), 145–154.
   PubMed Web of Science ®Google Scholar
• Wang HA, Boerman OC, Sariibrahimoglu K, Li YB, Jansen JA and Leeuwenburgh SCG: ‘Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphatase’, Biomaterials, 2012, 33, (33), 8695–8703.
   PubMed Web of Science ®Google Scholar
• Wang HN, Zou Q, Boerman OC, Nijhuis AWG, Jansen JA, Li YB and Leeuwenburgh SCG: ‘Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo’, J. Control. Release, 2013, 166, (2), 172–181.
   PubMed Web of Science ®Google Scholar
• Mithieux SM and Weiss AS: ‘Elastin’, Adv. Protein Chem., 2005, 70, 437–461.
   PubMedGoogle Scholar
• Kim W and Chaikof EL: ‘Recombinant elastin-mimetic biomaterials: emerging applications in medicine’, Adv. Drug Deliv. Rev., 2010, 62, (15), 1468–1478.
   PubMed Web of Science ®Google Scholar
• Rosenbloom J, Abrams WR and Mecham R: ‘Extracellular-matrix.4. The elastic fiber’, FASEB J., 1993, 7, (13), 1208–1218.
   PubMed Web of Science ®Google Scholar
• Mascaretti RS, Mataloun MM, Dolhnikoff M and Rebello CM: ‘Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits’, Clinics (Sao Paulo), 2009, 64, (11), 1099–1104.
   PubMed Web of Science ®Google Scholar
• Lee KW, Stolz DB and Wang Y: ‘Substantial expression of mature elastin in arterial constructs’, Proc. Natl. Acad. Sci. U.S.A., 2011, 108, (7), 2705–2710.
   PubMed Web of Science ®Google Scholar
• Gosline J, Lillie M, Carrington E, Guerette P, Ortlepp C and Savage K: ‘Elastic proteins: biological roles and mechanical properties’, Philos. Trans. R. Soc. Lond. B Biol. Sci., 2002, 357, (1418), 121–132.
   PubMed Web of Science ®Google Scholar
• Aaron BB and Gosline JM: ‘Elastin as a random-network elastomer – a mechanical and optical analysis of single elastin fibers’, Biopolymers, 1981, 20, (6), 1247–1260.
   Web of Science ®Google Scholar
• Hsueh YS, Savitha S, Sadhasivam S, Lin FH and Shieh MJ: ‘Design and synthesis of elastin-like polypeptides for an ideal nerve conduit in peripheral nerve regeneration’, Mater. Sci. Eng. C Mater. Biol. Appl., 2014, 38, 119–126.
   PubMed Web of Science ®Google Scholar
• Bozzini S, Giuliano L, Altomare L, Petrini P, Bandiera A, Conconi MT, Fare S and Tanzi MC: ‘Enzymatic cross-linking of human recombinant elastin (HELP) as biomimetic approach in vascular tissue engineering’, J. Mater. Sci. Mater. Med., 2011, 22, (12), 2641–2650.
   PubMed Web of Science ®Google Scholar
• Rincon AC, Molina-Martinez IT, de Las Heras B, Alonso M, Bailez C, Rodriguez-Cabello JC and Herrero-Vanrell R: ‘Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: in vitro and in vivo studies’, J. Biomed. Mater. Res. A, 2006, 78A, (2), 343–351.
   Web of Science ®Google Scholar
• Nettles DL, Chilkoti A and Setton LA: ‘Applications of elastin-like polypeptides in tissue engineering’, Adv. Drug Deliv. Rev., 2010, 62, (15), 1479–1485.
   PubMed Web of Science ®Google Scholar
• Shah M, Hsueh PY, Sun GY, Chang HY, Janib SM and MacKay JA: ‘Biodegradation of elastin-like polypeptide nanoparticles’, Protein Sci., 2012, 21, (6), 743–750.
   PubMed Web of Science ®Google Scholar
• Liu WE, Dreher MR, Furgeson DY, Peixoto KV, Yuan H, Zalutsky MR and Chilkoti A: ‘Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice’, J. Control. Release, 2006, 116, (2), 170–178.
   PubMed Web of Science ®Google Scholar
• Mackay JA and Chilkoti A: ‘Temperature sensitive peptides: engineering hyperthermia-directed therapeutics’, Int. J. Hyperthermia, 2008, 24, (6), 483–495.
   PubMed Web of Science ®Google Scholar
• Reiersen H, Clarke AR and Rees AR: ‘Short elastin-like peptides exhibit the same temperature-induced structural transitions as elastin polymers: implications for protein engineering’, J. Mol. Biol., 1998, 283, (1), 255–264.
   PubMed Web of Science ®Google Scholar
• Hassouneh W, MacEwan SR and Chilkoti A: ‘Fusions of elastin-like polypeptides to pharmaceutical proteins’, Methods Enzymol., 2012, 502, 215–237.
   PubMed Web of Science ®Google Scholar
• Chen TH, Bae Y, Furgeson DY and Kwon GS: ‘Biodegradable hybrid recombinant block copolymers for non-viral gene transfection’, Int. J. Pharm., 2012, 427, (1), 105–112.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jia Z, Li L and Chen F: ‘A genetically synthetic protein-based cationic polymer for siRNA delivery’, Med. Hypotheses, 2011, 76, (2), 239–240.
   PubMed Web of Science ®Google Scholar
• Amruthwar SS and Janorkar AV: ‘Preparation and characterization of elastin-like polypeptide scaffolds for local delivery of antibiotics and proteins’, J. Mater. Sci. Mater. Med., 2012, 23, (12), 2903–2912.
   PubMed Web of Science ®Google Scholar
• Machado R, Bessa PC, Reis RL, Rodriguez-Cabello JC and Casal M: ‘Elastin-based nanoparticles for delivery of bone morphogenetic proteins’, Methods Mol. Biol., 2012, 906, 353–363.
   PubMedGoogle Scholar
• Bidwell G.L. 3rd, Perkins E., Hughes J., Khan M., James J.R. and Raucher D.: ‘Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model’, PLoS One, 2013, 8, (1), e55104.
   PubMed Web of Science ®Google Scholar
• He XM and Carter DC: ‘Atomic structure and chemistry of human serum albumin’, Nature, 1992, 358, (6383), 209–215.
   PubMed Web of Science ®Google Scholar
• Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB and Miller TY: ‘Three-dimensional structure of human serum albumin’, Science, 1989, 244, (4909), 1195–1198.
   PubMed Web of Science ®Google Scholar
• Carter DC and Ho JX: ‘Structure of serum albumin’, Adv. Protein Chem., 1994, 45, 153–203.
   PubMedGoogle Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP and Jain RK: ‘Vascular-permeability in a human tumor xenograft – molecular-size dependence and cutoff size’, Cancer Res., 1995, 55, (17), 3752–3756.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y and Hori K: ‘Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review’, J. Control. Release, 2000, 65, (1–2), 271–284.
   PubMed Web of Science ®Google Scholar
• Fleischer S, Shapira A, Regev O, Nseir N, Zussman E and Dvir T: ‘: Albumin fiber scaffolds for engineering functional cardiac tissues’, Biotechnol. Bioeng., 2014, 111, (6), 1246–1257.
   PubMed Web of Science ®Google Scholar
• Puhl S, Li L, Meinel L and Germershaus O: ‘Controlled protein delivery from electrospun non-wovens: novel combination of protein crystals and a biodegradable release matrix’, Mol. Pharm., 2014, 11, (7), 2372–2380.
   PubMed Web of Science ®Google Scholar
• Rohanizadeh R and Kokabi N: ‘Heat denatured/aggregated albumin-based biomaterial: effects of preparation parameters on biodegradability and mechanical properties’, J. Mater. Sci. Mater. Med., 2009, 20, (12), 2413–2418.
   PubMed Web of Science ®Google Scholar
• Nseir N, Regev O, Kaully T, Blumenthal J, Levenberg S and Zussman E: ‘Biodegradable scaffold fabricated of electrospun albumin fibers: mechanical and biological characterization’, Tissue Eng. Part C Methods, 2013, 19, (4), 257–264.
   PubMed Web of Science ®Google Scholar
• Li YJ, Feng LZ, Shi XZ, Wang XJ, Yang YL, Yang K, Liu T, Yang GB and Liu Z: ‘Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene’, Small, 2014, 10, (8), 1544–1554.
   PubMed Web of Science ®Google Scholar
• Martinez A, Olmo R, Iglesias I, Teijon JM and Blanco MD: ‘Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization’, Pharm. Res., 2014, 31, (1), 182–193.
   PubMed Web of Science ®Google Scholar
• Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, Pan YH and Hu JH: ‘Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting’, Int. J. Pharm., 2008, 349, (1–2), 274–282.
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Buchel C, von Briesen H and Kreuter J: ‘Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones’, J. Control. Release, 2009, 137, (1), 78–86.
   PubMed Web of Science ®Google Scholar
• Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K and Vyas SP: ‘Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles’, J. Drug Target, 2006, 14, (1), 45–53.
   PubMed Web of Science ®Google Scholar
• Stollenwerk MM, Pashkunova-Martic I, Kremser C, Talasz H, Thurner GC, Abdelmoez AA, Wallnofer EA, Helbok A, Neuhauser E, Klammsteiner N, Klimaschewski L, von Guggenberg E, Frohlich E, Keppler B, Jaschke W and Debbage P: ‘Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation’, Histochem. Cell Biol., 2010, 133, (4), 375–404.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM and Elgindy NA: ‘Albumin-based nanoparticles as potential controlled release drug delivery systems’, J. Control. Release, 2012, 157, (2), 168–182.
   PubMed Web of Science ®Google Scholar
• Elsadek B and Kratz F: ‘Impact of albumin on drug delivery – new applications on the horizon’, J. Control. Release, 2012, 157, (1), 4–28.
   PubMed Web of Science ®Google Scholar
• Subramanian GM, Fiscella M, Lamouse-Smith A, Zeuzem S and McHutchison JG: ‘Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C’, Nat. Biotechnol., 2007, 25, (12), 1411–1419.
   PubMed Web of Science ®Google Scholar
• Walker A, Dunlevy G, Rycroft D, Topley P, Holt LJ, Herbert T, Davies M, Cook F, Holmes S, Jespers L and Herring C: ‘Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon’, Protein Eng. Des. Sel., 2010, 23, (4), 271–278.
   PubMed Web of Science ®Google Scholar
• Zhao HL, Xue C, Wang Y, Li XY, Xiong XH, Yao XQ and Liu ZM: ‘Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha 2b fusion protein by altering its orientation’, J. Biotechnol., 2007, 131, (3), 245–252.
   PubMed Web of Science ®Google Scholar
• Morales J: ‘Defining the role of insulin detemir in basal insulin therapy’, Drugs, 2007, 67, (17), 2557–2584.
   PubMed Web of Science ®Google Scholar
• Peterson GE: ‘Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir’, Curr. Med. Res. Opin., 2006, 22, (12), 2613–2619.
   PubMed Web of Science ®Google Scholar
• Ming X, Carver K and Wu L: ‘Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides’, Biomaterials, 2013, 34, (32), 7939–7949.
   PubMed Web of Science ®Google Scholar
• Zhang SF, Wang GL, Lin XY, Chatzinikolaidou M, Jennissen HP, Laub M and Uludag H: ‘Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery’, Biotechnol. Prog., 2008, 24, (4), 945–956.
   PubMed Web of Science ®Google Scholar
• Shaw JTB and Smith SG: ‘Amino-acids of silk sericin’, Nature, 1951, 168, (4278), 745–745.
   PubMed Web of Science ®Google Scholar
• Wang YJ and Zhang YQ: ‘Three-layered sericins around the silk fibroin fiber from Bombyx mori cocoon and their amino acid composition’, Adv. Mater. Res., 2011, 175–176, 158–163.
   Google Scholar
• Schroeder WA and Kay LM: ‘The amino acid composition of bombyx-mori silk fibroin and of tussah silk fibroin’, J. Am. Chem. Soc., 1955, 77, (14), 3908–3913.
   Web of Science ®Google Scholar
• Warwicker JO: ‘Comparative studies of fibroins. 2. Crystal structures of various fibroins’, J. Mol. Biol., 1960, 2, (6), 350–362.
   PubMed Web of Science ®Google Scholar
• Giesa T, Arslan M, Pugno NM and Buehler MJ: ‘Nanoconfinement of spider silk fibrils begets superior strength, extensibility, and toughness’, Nano Lett., 2011, 11, (11), 5038–5046.
   PubMed Web of Science ®Google Scholar
• Vollrath F and Knight DP: ‘Liquid crystalline spinning of spider silk’, Nature, 2001, 410, (6828), 541–548.
   PubMed Web of Science ®Google Scholar
• Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen JS, Lu H, Richmond J and Kaplan DL: ‘Silk-based biomaterials’, Biomaterials, 2003, 24, (3), 401–416.
   PubMed Web of Science ®Google Scholar
• Scheibel T: ‘Protein fibers as performance proteins: new technologies and applications’, Curr. Opin. Biotechnol., 2005, 16, (4), 427–433.
   PubMed Web of Science ®Google Scholar
• Vepari C and Kaplan DL: ‘Silk as a biomaterial’, Prog. Polym. Sci., 2007, 32, (8–9), 991–1007.
   PubMed Web of Science ®Google Scholar
• Omenetto FG and Kaplan DL: ‘A new route for silk’, Nat. Photon., 2008, 2, (11), 641–643.
   Web of Science ®Google Scholar
• Tsioris K, Raja WK, Pritchard EM, Panilaitis B, Kaplan DL and Omenetto FG: ‘Fabrication of silk microneedles for controlled-release drug delivery’, Adv. Funct. Mater., 2012, 22, (2), 330–335.
   Web of Science ®Google Scholar
• Uebersax L, Apfel T, Nuss KMR, Vogt R, Kim HY, Meinel L, Kaplan DL, Auer JA, Merkle HP and von RB: ‘Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep’, Eur. J. Pharm. Biopharm., 2013, 85, (1), 107–118.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Hilbe M, Fajardo RJ, Hagenmuller H, Nuss K, Arras M, Muller R, von RB, Kaplan DL, Merkle HP and Meinel L: ‘Remodeling of tissue-engineered bone structures in vivo’, Eur. J. Pharm. Biopharm., 2013, 85, (1), 119–129.
   PubMed Web of Science ®Google Scholar
• Meinel L and Kaplan DL: ‘Silk constructs for delivery of musculoskeletal therapeutics’, Adv. Drug Deliv. Rev., 2012, 64, (12), 1111–1122.
   PubMed Web of Science ®Google Scholar
• Meinel AJ, Kubow KE, Klotzsch E, Garcia-Fuentes M, Smith ML, Vogel V, Merkle HP and Meinel L: ‘Optimization strategies for electrospun silk fibroin tissue engineering scaffolds’, Biomaterials, 2009, 30, (17), 3058–3067.
   PubMed Web of Science ®Google Scholar
• Uebersax L, Merkle HP and Meinel L: ‘Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells’, J. Control. Release, 2008, 127, (1), 12–21.
   PubMed Web of Science ®Google Scholar
• Uebersax L, Mattotti M, Papaloizos M, Merkle HP, Gander B and Meinel L: ‘Silk fibroin matrices for the controlled release of nerve growth factor (NGF)’, Biomaterials, 2007, 28, (30), 4449–4460.
   PubMed Web of Science ®Google Scholar
• Kirker-Head C, Karageorgiou V, Hofmann S, Fajardo R, Betz O, Merkle HP, Hilbe M, von RB, McCool J, Abrahamsen L, Nazarian A, Cory E, Curtis M, Kaplan D and Meinel L: ‘BMP-silk composite matrices heal critically sized femoral defects’, Bone, 2007, 41, (2), 247–255.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Knecht S, Langer R, Kaplan DL, Vunjak-Novakovic G, Merkle HP and Meinel L: ‘Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells’, Tissue Eng., 2006, 12, (10), 2729–2738.
   PubMedGoogle Scholar
• Yang YM, Chen XM, Ding F, Zhang PY, Liu J and Go XS: ‘Biocompatibility evaluation of silk fibroin with peripheral nerve tissues and cells in vitro’, Biomaterials, 2007, 28, (9), 1643–1652.
   PubMed Web of Science ®Google Scholar
• Acharya C, Ghosh SK and Kundu SC: ‘Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion’, J. Mater. Sci. Mater. Med., 2008, 19, (8), 2827–2836.
   PubMed Web of Science ®Google Scholar
• Bessa PC, Balmayor ER, Hartinger J, Zanoni G, Dopler D, Meinl A, Banerjee A, Casal M, Redl H, Reis RL and van Griensven M: ‘Silk fibroin microparticles as carriers for delivery of human recombinant bone morphogenetic protein-2: in vitro and in vivo bioactivity’, Tissue Eng. Part C Methods, 2010, 16, (5), 937–945.
   PubMed Web of Science ®Google Scholar
• Santin M, Motta A, Freddi G and Cannas M: ‘In vitro evaluation of the inflammatory potential of the silk fibroin’, J. Biomed. Mater. Res., 1999, 46, (3), 382–389.
   PubMed Web of Science ®Google Scholar
• Meinel L, Hofmann S, Karageorgiou V, Kirker-Head C, McCool J, Gronowicz G, Zichner L, Langer R, Vunjak-Novakovic G and Kaplan DL: ‘The inflammatory responses to silk films in vitro and in vivo’, Biomaterials, 2005, 26, (2), 147–155.
   PubMed Web of Science ®Google Scholar
• Mandal BB, Priya AS and Kundu SC: ‘Novel silk sericin/gelatin 3-D scaffolds and 2-D films: fabrication and characterization for potential tissue engineering applications’, Acta Biomater., 2009, 5, (8), 3007–3020.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee M, Schultz-Thater E, Trella E, Miot S, Das S, Loparic M, Ray AR, Martin I, Spagnoli GC and Ghosh S: ‘The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials’, Biomaterials, 2013, 34, (33), 8161–8171.
   PubMed Web of Science ®Google Scholar
• Panilaitis B, Altman GH, Chen JS, Jin HJ, Karageorgiou V and Kaplan DL: ‘Macrophage responses to silk’, Biomaterials, 2003, 24, (18), 3079–3085.
   PubMed Web of Science ®Google Scholar
• Hu YP, Zhang Q, You RC, Wang LS and Li MZ: ‘The relationship between secondary structure and biodegradation behavior of silk fibroin scaffolds’, Adv. Mater. Sci. Eng., 2012, 2012, 5.
   Web of Science ®Google Scholar
• Wang Y, Rudym DD, Walsh A, Abrahamsen L, Kim HJ, Kim HS, Kirker-Head C and Kaplan DL: ‘In vivo degradation of three-dimensional silk fibroin scaffolds’, Biomaterials, 2008, 29, (24–25), 3415–3428.
   PubMed Web of Science ®Google Scholar
• Uebersax L, Merkle HP and Meinel L: ‘Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems’, Tissue Eng., Part B, 2009, 15, (3), 263–289.
   PubMed Web of Science ®Google Scholar
• Wenk E, Wandrey AJ, Merkle HP and Meinel L: ‘Silk fibroin spheres as a platform for controlled drug delivery’, J. Control. Release, 2008, 132, (1), 26–34.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Wong PFCT, Rossetti F, Textor M, Vunjak-Novakovic G, Kaplan DL, Merkle HP and Meinel L: ‘Silk fibroin as an organic polymer for controlled drug delivery’, J. Control. Release, 2006, 111, (1–2), 219–227.
   PubMed Web of Science ®Google Scholar
• Meinel L, Hofmann S, Karageorgiou V, Zichner L, Langer R, Kaplan D and Vunjak-Novakovic G: ‘Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds’, Biotechnol. Bioeng., 2004, 88, (3), 379–391.
   PubMed Web of Science ®Google Scholar
• Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V, Zichner L, Kaplan D, Langer R and Vunjak-Novakovic G: ‘Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow’, Ann. Biomed. Eng., 2004, 32, (1), 112–122.
   PubMed Web of Science ®Google Scholar
• Meinel L, Karageorgiou V, Hofmann S, Fajardo R, Snyder B, Li C, Zichner L, Langer R, Vunjak-Novakovic G and Kaplan DL: ‘Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds’, J. Biomed. Mater. Res. Part A, 2004, 71A, (1), 25–34.
   Web of Science ®Google Scholar
• Uebersax L, Fedele DE, Schumacher C, Kaplan DL, Merkle HP, Boison D and Meinel L: ‘The support of adenosine release from adenosine kinase deficient ES cells by silk substrates’, Biomaterials, 2006, 27, (26), 4599–4607.
   PubMed Web of Science ®Google Scholar
• Karageorgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K, Chen J, Vunjak-Novakovic G and Kaplan DL: ‘Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo’, J. Biomed. Mater. Res. Part A, 2006, 78A, (2), 324–334.
   Web of Science ®Google Scholar
• Pritchard EM, Dennis PB, Omenetto F, Naik RR and Kaplan DL: ‘Physical and chemical aspects of stabilization of compounds in silk’, Biopolymers, 2012, 97, (6), 479–498.
   PubMed Web of Science ®Google Scholar
• Wenk E, Merkle HP and Meinel L: ‘Silk fibroin as a vehicle for drug delivery applications’, J. Control. Release, 2011, 150, (2), 128–141.
   PubMed Web of Science ®Google Scholar
• Biondi M, Ungaro F, Quaglia F and Netti PA: ‘Controlled drug delivery in tissue engineering’, Adv. Drug Deliv. Rev., 2008, 60, (2), 229–242.
   PubMed Web of Science ®Google Scholar
• Jin H.-J and Kaplan DL: ‘Mechanism of silk processing in insects and spiders’, Nature, 2003, 424, (6952), 1057–1061.
   PubMed Web of Science ®Google Scholar
• Cohen S and Bernstein H: ‘ Microparticulate systems for the delivery of proteins and vaccines’, in ‘Drugs and the pharmaceutical sciences’, Vol. Vol. 77, 525; 1996, New York, Marcel Dekker Inc.
   Google Scholar
• Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V and Kaplan D: ‘Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells’, J. Biomed. Mater. Res. Part A, 2004, 71A, (3), 528–537.
   Web of Science ®Google Scholar
• Sofia S, McCarthy MB, Gronowicz G and Kaplan DL: ‘Functionalized silk-based biomaterials for bone formation’, J. Biomed. Mater. Res., 2000, 54, (1), 139–148.
   Web of Science ®Google Scholar
• Lu Q, Wang X, Zhu H and Kaplan DL: ‘Surface immobilization of antibody on silk fibroin through conformational transition’, Acta Biomater., 2011, 7, (7), 2782–2786.
   PubMed Web of Science ®Google Scholar
• Lv Q, Hu K, Feng Q and Cui F: ‘Fibroin/collagen hybrid hydrogels with crosslinking method: preparation, properties, and cytocompatibility’, J. Biomed. Mater. Res. A, 2008, 84, (1), 198–207.
   PubMed Web of Science ®Google Scholar
• Wenk E, Murphy AR, Kaplan DL, Meinel L, Merkle HP and Uebersax L: ‘The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration’, Biomaterials, 2010, 31, (6), 1403–1413.
   PubMed Web of Science ®Google Scholar
• Murphy AR, St JP and Kaplan DL: ‘Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation’, Biomaterials, 2008, 29, (19), 2829–2838.
   PubMed Web of Science ®Google Scholar
• Zhao HS, Heusler E, Jones G, Li LH, Werner V, Germershaus O, Ritzer J, Luehmann T and Meinel L: ‘Decoration of silk fibroin by click chemistry for biomedical application’, J. Struct. Biol., 2014, 186, (3), 420–430.
   PubMed Web of Science ®Google Scholar
• Fekner T, Li X, Lee MM and Chan MK: ‘A pyrrolysine analogue for protein click chemistry’, Angew. Chem. Int. Ed. Engl., 2009, 48, (9), 1633–1635.
   PubMed Web of Science ®Google Scholar
• Gaston MA, Jiang R and Krzycki JA: ‘Functional context, biosynthesis, and genetic encoding of pyrrolysine’, Curr. Opin. Microbiol., 2011, 14, (3), 342–349.
   PubMed Web of Science ®Google Scholar
• Hertweck C: ‘Biosynthesis and charging of pyrrolysine, the 22nd genetically encoded amino acid’, Angew. Chem. Int. Ed. Engl., 2011, 50, (41), 9540–9541.
   PubMed Web of Science ®Google Scholar
• Wang X, Wenk E, Zhang X, Meinel L, Vunjak-Novakovic G and Kaplan DL: ‘Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering’, J. Control. Release, 2009, 134, (2), 81–90.
   PubMed Web of Science ®Google Scholar
• Zhang J, Pritchard E, Hu X, Valentin T, Panilaitis B, Omenetto FG and Kaplan DL: ‘Stabilization of vaccines and antibiotics in silk and eliminating the cold chain’, Proc. Natl. Acad. Sci. U.S.A, 2012, 109, (30), 11981–11986.
   PubMed Web of Science ®Google Scholar
• Colinet G, Rossignol J and Peetermans J: ‘A study of the stability of a bivalent measles–mumps vaccine’, J. Biol. Stand., 1982, 10, (4), 341–346.
   PubMedGoogle Scholar
• Clementi F: ‘Alginate production by Azotobacter vinelandii’, Crit. Rev. Biotechnol., 1997, 17, (4), 327–361.
   PubMed Web of Science ®Google Scholar
• Hay ID, Rehman ZU, Ghafoor A and Rehm BHA: ‘Bacterial biosynthesis of alginates’, J. Chem. Technol. Biot., 2010, 85, (6), 752–759.
   Web of Science ®Google Scholar
• Dhillon GS, Kaur S, Brar SK and Verma M: ‘Green synthesis approach: extraction of chitosan from fungus mycelia’, Crit. Rev. Biotechnol., 2013, 33, (4), 379–403.
   PubMed Web of Science ®Google Scholar